Caption Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Hold
850,000
0.01% 961
2026
Q1
$1.08M Buy
+850,000
New +$1.6M 0.01% 1005
2022
Q2
Sell
-30,000
Closed -$784K 1601
2022
Q1
$784K Hold
30,000
0.01% 1038
2021
Q4
$1.19M Buy
30,000
+10,000
+50% +$456K 0.01% 980
2021
Q3
$1M Hold
20,000
0.01% 1018
2021
Q2
$1.11M Buy
+20,000
New +$1.07M 0.01% 866

Other funds holding HCAT

Caption Management's HCAT Position: Q2 2026 in Review

Caption Management increased its Health Catalyst (HCAT) stake by 0.23% in Q2 2026, buying an estimated $2.55K and bringing the position to 773,650 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #987.

Caption Management first reported a position in HCAT in Q2 2021 and has held it in 8 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Caption Management held 773,650 shares of Health Catalyst worth $1.54M as of Q2 2026.
  • Caption Management bought 1,764 Health Catalyst shares in Q2 2026, an estimated $2.55K.
  • Health Catalyst made up 0.01% of Caption Management's portfolio in Q2 2026, its #987 holding.
  • Caption Management first reported a position in Health Catalyst in Q2 2021 and has held it in 8 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.